Published in Oncotarget on September 28, 2016
Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell (2003) 14.07
High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer (2010) 7.39
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res (2005) 7.34
SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet (2009) 5.01
MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer (2011) 3.91
The H19 non-coding RNA is essential for human tumor growth. PLoS One (2007) 3.75
Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) (2006) 3.74
Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet (2009) 3.72
Small RNAs: classification, biogenesis, and function. Mol Cells (2005) 3.59
The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 3.27
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene (2007) 3.11
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
SNPs in human miRNA genes affect biogenesis and function. RNA (2009) 2.08
The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A (2008) 1.98
The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res (2010) 1.88
Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis (2012) 1.65
Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt. Mol Cell Biol (2004) 1.35
Heritability of cervical tumours. Int J Cancer (2000) 1.32
Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J (2013) 1.26
miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat (2010) 1.26
Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep (2012) 1.22
MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther (2010) 1.17
Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget (2015) 1.16
Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol (2011) 1.15
MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life (2012) 1.05
miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. J Invest Surg (2012) 0.93
Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat Res (2014) 0.91
The huge world of small RNAs: regulating networks of microRNAs (review). Acta Physiol Hung (2011) 0.79
Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population. Oncotarget (2016) 0.77
PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population. Oncotarget (2016) 0.75
TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han population. Oncotarget (2017) 0.75
Associations between polymorphisms in the IL-4 gene and renal cell carcinoma in Chinese Han population. Oncotarget (2017) 0.75